Genome-wide pathway analysis in neuroblastoma

Area of Science:

• Genetics and Genomics
• Cancer Research
• Bioinformatics

Background:

• Neuroblastoma is a pediatric cancer with complex genetic underpinnings.
• Identifying genetic variants associated with neuroblastoma susceptibility is crucial for understanding disease mechanisms.

Purpose of the Study:

• To identify candidate single-nucleotide polymorphisms (SNPs) associated with neuroblastoma susceptibility.
• To elucidate potential biological mechanisms involving identified SNPs, genes, and pathways.
• To generate hypotheses regarding SNP-gene-pathway interactions in neuroblastoma.

Main Methods:

• Genome-wide association study (GWAS) dataset analysis of 1,627 neuroblastoma patients and 3,254 controls.
• Application of the identify candidate causal SNPs and pathways (ICSNPathway) analysis tool.
• Statistical analysis to identify significant SNPs, genes, and pathways.

Main Results:

• Identified 15 candidate SNPs, 10 genes (including IL3, BARD1, CFL1), and 31 pathways potentially involved in neuroblastoma.
• Revealed 10 hypothetical biological mechanisms, with the strongest involving SNPrs40401 modulating IL3.
• Second and third strongest mechanisms involved rs1048108/rs16852600 altering BARD1 function and rs1939212 modulating CFL1.

Conclusions:

• The ICSNPathway analysis successfully identified potential genetic contributors to neuroblastoma susceptibility.
• Candidate SNPs, genes, and pathways provide a foundation for further research into neuroblastoma pathogenesis.
• Hypothesized mechanisms offer insights into how genetic variations may influence disease development.